Does BRENTUXIMAB Cause Malignant neoplasm progression? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Malignant neoplasm progression have been filed in association with BRENTUXIMAB. This represents 7.2% of all adverse event reports for BRENTUXIMAB.
13
Reports of Malignant neoplasm progression with BRENTUXIMAB
7.2%
of all BRENTUXIMAB reports
7
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BRENTUXIMAB?
Of the 13 reports, 7 (53.8%) resulted in death, 7 (53.8%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRENTUXIMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does BRENTUXIMAB Cause?
Off label use (40)
Drug ineffective (30)
Disease progression (23)
Febrile neutropenia (14)
Neuropathy peripheral (10)
Product use in unapproved indication (9)
Tubulointerstitial nephritis (9)
Acute kidney injury (8)
Pancytopenia (8)
Sepsis (8)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BRENTUXIMAB Alternatives Have Lower Malignant neoplasm progression Risk?
BRENTUXIMAB vs BRENTUXIMAB VEDOTIN
BRENTUXIMAB vs BREO ELLIPTA
BRENTUXIMAB vs BREXANOLONE
BRENTUXIMAB vs BREXPIPRAZOLE
BRENTUXIMAB vs BREXUCABTAGENE AUTOLEUCEL